Evotec Se's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Evotec Se's ROA in the fourth quarter of 2025?
Evotec Se recorded a cumulative net loss of $-116 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -5.86%.

However, within the Healthcare sector 311 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 3534.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	78.31 %	78.31 %	78.31 %	78.31 %	-11.5 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-116	-220	-220	-220	-220
Return On Assets (TTM)	-5.86 %	-12.46 %	-14.21 %	-16.54 %	-19.78 %
EVO's Total Ranking	# 3534	#	#	#	# 3857
Total Assets (TTM) in million	1,980	1,980	1,980	1,980	1,110
Seq. Total Assets Change	0 %	0 %	0 %	78.31 %	0 %
Seq. Net Income Change	-	-	-	-	-

EVO's 5 Years Annual ROA >> Back to EVO Management Effectiveness >> Compare EVO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 114
Sector	# 312
Overall	# 3507

Return On Assets Statistics
High	Average	Low
-3.73 %	-6.95 %	-10.25 %
(Dec 31 2023)		(Dec 31 2024)

Financial Statements
Evotec Se's Assets	$ 1,980 million	EVO's Balance sheet
Evotec Se's Income	$ -116 million	Quarterly EVO's Income Statement
EVO's Income by Division		See EVO's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	7.63 %	-2.06 %	-55.16 %	6.03 %	-
Total Assets in million	1,195	1,110	1,134	2,528	2,384
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-116	-220	-94	-197	241
Annual Return On Assets	-9.7 %	-19.78 %	-8.29 %	-7.78 %	10.12 %

EVO's 5 Years Annual ROA >> Back to EVO Management Effectiveness >> Compare EVO ROA to its Competitors

More Return On Assets Ratios
EVO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EVO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EVO's Competitors
Subscribers only: Roa for Evotec Se's Suppliers
Subscribers only: Return On Assets for EVO's Customers

You may also want to know
EVO's Roi	EVO's Inventory Turnover Ratio	EVO's Growth Rates	EVO's Dividend Comparisons
	EVO's Profitability Ratios	EVO's Asset Turnover Ratio	EVO's Dividend Growth
EVO's Roe	EVO's Valuation Ratios	EVO's Financial Strength Ratios	EVO's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T10:39:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.